pembrolizumab,enfortumab vedotin,olaparib
astellas,seagen,merck,astrazeneca
['$mrk', 'merck']
merck to present new data at esmo 2022 congress from its broad oncology portfolio and promising pipeline, demonstrating commitment to improving long-term survival.. $mrk 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice